🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Deep Versus Moderate Neuromuscular Blocking

RecruitingNAAges 18 Years - 60 YearsFemaleMenoufia University
NCT07485517 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aimed for Determination of the impacts of deep neuromuscular blockade (DNMB) on surgical outcomes, consumption of perioperative opioid analgesia, and serum levels of inflammatory cytokines in comparison to moderate NMB (MNMB).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Women who will be admitted to undergo elective hysterectomy ,-ASA grade I or II, * Body mass index (BMI) of \<35 kg/m2 Exclusion Criteria: hemoglobin concentration of ≤7 gm%, * the presence of neuromuscular disorders * uncontrolled medical diseases * autoimmune diseases, maintenance on immunosuppressant therapy for any indication * refusal to sign the written consent
💊

What it tests

  • Moderate Neuromuscular Blockade
  • Deep neuromuscular block
📍

Where

1 site
Faculty of Medicine Menoufia University
Menoufia, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy